Kevin Bruce Johnson is Chief Regulatory Officer of Talaris Therapeutics, Inc.. Currently has a direct ownership of 57,834 shares of TALS, which is worth approximately $157,308. The most recent transaction as insider was on Oct 19, 2023, when has been sold 57,834 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.8K
0% 3M change
n/a 12M change
Total Value Held $157,308

Kevin Bruce Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 19 2023
BUY
Grant, award, or other acquisition
-
57,834 Added 50.0%
57,834 Common Stock
KBJ

Kevin Bruce Johnson

Chief Regulatory Officer
New York, NY

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Track Activities on TALS